A recent study indicates that patients who come off popular GLP-1 drugs like semaglutide or tirzepatide may regain reduced body mass much more quickly than those who halt conventional diet and exercise regimens.
Findings released in a major health publication demonstrates that while overweight individuals often shed a large proportion of their total mass while using the jabs, the weight comes back at an average rate of 0.8 kg per month after stopping.
"People purchasing such drugs must be cognizant of the risk of quick rebound weight gain when the treatment concludes," cautioned researcher Dr. Susan Jebb.
Such speed of recovery implies a reversion to original weight within about one and a half years.
Weighing Approaches
The study, which examined dozens of trials involving thousands of patients, contrasted the outcomes of these new drugs with other pills.
Researchers emphasize that individuals who lose weight through diet and exercise usually see a slower weight regain—perhaps 100 grams monthly—post-intervention.
Understanding the Fast Regain
Nutrition scientists suggest the mode of action of the jabs explains the amplified weight return.
The injections copy a body's own chemical called GLP-1, which controls feelings of fullness.
"Long-term administration of the hormone concentrations far above than normal may cause the system to generate a reduced amount of its own natural GLP-1, and could lessen responsiveness to its effects," explained Dr. Adam Collins, a nutrition researcher.
"Discontinuation of this medication means appetite is uncontrolled, making overeating far more likely."
A Lifelong Condition?
Medical guidelines advise the jabs for individuals with weight-linked health risks, alongside recommended lifestyle changes.
Professionals argue that, due to the high risk of weight regain, the therapy might need to be life-long.
This view is supported by pharmaceutical companies, who state that the results "highlight the persistent nature of excess weight," similar to managing diseases like hypertension.
User Accounts
People who have come off the jabs explain a sudden return of hunger.
"It was like a switch that goes on and you're instantly ravenous," recalled a patient.
The struggle is compounded if users have not established permanent dietary or behavioural modifications during therapy.
Significant Interest
Recent estimates indicate that millions of adults in the UK have tried these injections in the past year, with demand remaining high.
- Adoption is more common among women than males.
- The 40s and 50s demographic shows the greatest level of interest.
- Many obtain the drugs through private healthcare rather than public health services.
In conclusion, researchers caution that while the jabs are powerful agents for shedding pounds, they are not a magic solution and lasting health benefits likely depends on integrated behavioural support.
